Commodore Capital
Healthcare Investment FirmNew York, United StatesSee on the mapcommodorecapital.com
Health specialist
Commodore Capital is an investment firm focused on biopharmaceutical companies developing medicines for patients.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 12
- Open roles in the portfolio
- Jul 2026
- Latest portfolio round
Hiring now in the portfolio12
Apply on each company's site- Posted 5d ago
Senior Director, Data Management
Alto Neuroscience · Mountain View, CA
- Posted 24d ago
Senior Manager, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Senior Manager/Director of Contracts and Procurement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Manager, Patient Recruitment & Engagement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
VP, Commercial Planning
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Clinical Trial Associate
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Associate Director, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Manager, Clinical Science & Site Educator
Alto Neuroscience · Remote (US)
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Alto NeuroscienceLos Altos, CA
- Jul 2026Post-IPO Equity (PIPE) · $100MLed
- Mar 2026Post-IPO Equity (PIPE) · $120MLed
- Oct 2025Post-IPO Equity (PIPE) · $50MLed
- Jul 2024Grant · $11.7M
- Nov 2023Venture Round · $59.3M
- Nov 2023Series C · $45M
- LeonaBioBothell, Washington, United States
- Dec 2025Post-IPO Equity · $90MLed
- Jan 2021Post-IPO Equity · $104MLed
- Dec 2020Grant · $15M
- Sep 2020Convertible Note
- Jun 2020Series B · $85M
- Jun 2020Unknown · $90.9M
Rounds marked Led list Commodore Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Jul 2026
Alto Neuroscience · Post-IPO Equity (PIPE) $100MLead
With EcoR1 Capital, LLC
- Mar 2026
Alto Neuroscience · Post-IPO Equity (PIPE) $120MLead
With Dellora Investments, Driehaus Capital Management, Perceptive Advisors, Spruce Street Capital, Venrock Healthcare Capital Partners, Vestal Point Capital, EcoR1 Capital, LLC
- Dec 2025
LeonaBio · Post-IPO Equity $90MLead
With TCGX, Perceptive Advisors, TCG Crossover
- Oct 2025
Alto Neuroscience · Post-IPO Equity (PIPE) $50MLead
With Perceptive Advisors, Vestal Point Capital, Vivo Capital
- Jan 2021
LeonaBio · Post-IPO Equity $104MLead
With TCGX, Perceptive Advisors
- Undated
LeonaBio · Series A $246MLead